{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:31:26Z","timestamp":1772166686121,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Impella is an advanced ventricular assist device frequently used as a bridge to heart transplantation. The association of Impella with increased rates of gout flares has not been studied. Our primary aim is to determine the rates of gout flares in patients on Impella support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>A retrospective study was conducted between January 2017 and September 2022 involving all patients who underwent heart transplantation. The cohort was divided into two groups based on Impella support for statistical analysis. In patients receiving Impella support, outcome measures were compared based on the development of gout flares. 1:1 nearest neighbor propensity match, as well as inverse propensity of treatment weighted analyses, were performed to explore the causal relationship between impella use and gout flare in our study population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our analysis included 213 patients, among which 42 (19.71%) patients were supported by Impella. Impella and non-Impella groups had similar age, race, and BMI, but more males were in the Impella group. Gout and chronic kidney disease were more prevalent in Impella-supported patients, while coronary artery disease was less common. The prevalence of gout flare was significantly higher in Impella patients (30.9% vs. 5.3%). 42 Impella-supported patients were matched with 42 patients from the non-impella group upon performing a 1:1 propensity matching. Impella-supported patients were noted to have a significantly higher risk of gout flare (30.9% vs. 7.1%, SMD\u2009=\u20090.636), despite no significant difference in pre-existing gout history and use of anti-gout medications. Impella use was associated with a significantly increased risk of gout flare in unadjusted (OR 8.07), propensity-matched (OR 5.83), and the inverse propensity of treatment-weighted analysis (OR 4.21).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study is the first to identify the potential association between Impella support and increased rates of gout flares in hospitalized patients. Future studies are required to confirm this association and further elucidate the biological pathways. It is imperative to consider introducing appropriate measures to prevent and promptly manage gout flares in Impella-supported patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-024-00380-z","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:02:33Z","timestamp":1709164953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between Impella device support and elevated rates of gout flares: a retrospective propensity-matched study"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7556-8851","authenticated-orcid":false,"given":"Jorge","family":"Sinclair De Fr\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-6395","authenticated-orcid":false,"given":"Shahin","family":"Isha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2358-9527","authenticated-orcid":false,"given":"Lorenzo","family":"Olivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekhya","family":"Raavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Abhishek","family":"Narra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smit","family":"Paghdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhana","family":"Jonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parthkumar","family":"Satashia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Blasavage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layton","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titilope","family":"Olanipekun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Kiley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Nativ\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Lyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basar","family":"Sareyyupoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-5599","authenticated-orcid":false,"given":"Pablo","family":"Moreno Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-5895","authenticated-orcid":false,"given":"Parag","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-8963","authenticated-orcid":false,"given":"Devang","family":"Sanghavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"issue":"02","key":"380_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/s-0038-1676369","volume":"28","author":"JJ Glazier","year":"2019","unstructured":"Glazier JJ, Kaki A. The Impella device: historical background, clinical applications and future directions. Int J Angiol. 2019;28(02):118\u201323.","journal-title":"Int J Angiol"},{"key":"380_CR2","doi-asserted-by":"publisher","unstructured":"Zein R, Patel C, Mercado-Alamo A, Schreiber T, Kaki A. A Review of the Impella Devices. Interventional Cardiology. 2022;17:e05 [Internet]. 2022; https:\/\/doi.org\/10.15420\/icr.2021.11.","DOI":"10.15420\/icr.2021.11"},{"issue":"1","key":"380_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13019-022-01871-1","volume":"17","author":"JR Rock","year":"2022","unstructured":"Rock JR, Kos CA, Lemaire A, Ikegami H, Russo MJ, Moin D, et al. Single center first year experience and outcomes with impella 5.5 left ventricular assist device. J Cardiothorac Surg. 2022;17(1):124.","journal-title":"J Cardiothorac Surg"},{"issue":"5","key":"380_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cardfail.2022.03.183","volume":"28","author":"FHA Tonleu","year":"2022","unstructured":"Tonleu FHA, Zapata D, Daneshmand M, Staloch D, Agrawal A. Outcomes with Impella 5.0 and 5.5 in cardiogenic shock. J Card Fail. 2022;28(5):72.","journal-title":"J Card Fail"},{"key":"380_CR5","doi-asserted-by":"crossref","unstructured":"Cevasco M, Shin M, Cohen W, Helmers MR, Weingarten N, Rekhtman D et al. Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States. Clin Transplant. 2023;e15066.","DOI":"10.1111\/ctr.15066"},{"issue":"2","key":"380_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.17925\/HI.2020.14.2.92","volume":"14","author":"GW Vetrovec","year":"2020","unstructured":"Vetrovec GW, Kaki A, Dahle TG, Centracare, Heart & Vascular Center, St. Cloud Hospital, St. Cloud, MN, USA. A review of bleeding risk with impella-supported high-risk percutaneous coronary intervention. Heart Int. 2020;14(2):92.","journal-title":"Heart Int"},{"issue":"7","key":"380_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM. American College of Physicians, American Physiological Society. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499\u2013516.","journal-title":"Ann Intern Med"},{"key":"380_CR8","doi-asserted-by":"crossref","unstructured":"Textor J, Van Der Zander B, Gilthorpe MS, Li\u015bkiewicz M, Ellison GTH. Robust causal inference using directed acyclic graphs: the R package \u2018dagitty\u2019. Int J Epidemiol. 2017;dyw341.","DOI":"10.1093\/ije\/dyw341"},{"key":"380_CR9","doi-asserted-by":"crossref","unstructured":"Ho DE, Imai K, King G, Stuart EA. MatchIt: Nonparametric Preprocessing for Parametric Causal Inference. J Stat Soft [Internet]. 2011 [cited 2024 Jan 14];42(8). Available from: http:\/\/www.jstatsoft.org\/v42\/i08\/.","DOI":"10.18637\/jss.v042.i08"},{"issue":"9","key":"380_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40266-021-00876-0","volume":"38","author":"LJ Seppala","year":"2021","unstructured":"Seppala LJ, Van De Loo B, Schut M, Van Schoor NM, Stricker BH, Kenny RA, et al. A propensity score matched Approach to assess the associations of commonly prescribed medications with fall risk in a large Harmonized Cohort of older ambulatory persons. Drugs Aging. 2021;38(9):797\u2013805.","journal-title":"Drugs Aging"},{"issue":"7","key":"380_CR11","doi-asserted-by":"publisher","first-page":"e2822","DOI":"10.1097\/MD.0000000000002822","volume":"95","author":"P Su","year":"2016","unstructured":"Su P, Hong L, Zhao Y, Sun H, Li L. The Association between Hyperuricemia and Hematological indicators in a Chinese Adult Population. Med (Baltim). 2016;95(7):e2822.","journal-title":"Med (Baltim)"},{"issue":"21","key":"380_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood.V124.21.1362.1362","volume":"124","author":"C Kumkhaek","year":"2014","unstructured":"Kumkhaek C, Shriner D, Doumatey AP, Rotimi CN, Rodgers GP. An Intergenic SNP in the \u03b2\u2013globin gene cluster is Associated with Hyperuricemia and influences Gene transcription in Vitro. Blood. 2014;124(21):1362\u20132.","journal-title":"Blood"},{"key":"380_CR13","doi-asserted-by":"crossref","unstructured":"Lauten A, Engstr\u00f6m AE, Jung C, Empen K, Erne P, Cook S et al. Percutaneous Left-Ventricular Support With the Impella-2.5\u2013Assist Device in Acute Cardiogenic Shock: Results of the Impella\u2013EUROSHOCK-Registry. Circ: Heart Failure. 2013;6(1):23\u201330.","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224"},{"issue":"1","key":"380_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MAT.0000000000000290","volume":"62","author":"AP Badiye","year":"2016","unstructured":"Badiye AP, Hernandez GA, Novoa I, Chaparro SV. Incidence of Hemolysis in patients with cardiogenic shock treated with Impella Percutaneous Left Ventricular assist device. ASAIO J. 2016;62(1):11\u20134.","journal-title":"ASAIO J"},{"issue":"4","key":"380_CR15","first-page":"338","volume":"8","author":"DM Ouweneel","year":"2019","unstructured":"Ouweneel DM, De Brabander J, Karami M, Sjauw KD, Engstr\u00f6m AE, Vis MM, et al. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience. Eur Heart Journal: Acute Cardiovasc Care. 2019;8(4):338\u201349.","journal-title":"Eur Heart Journal: Acute Cardiovasc Care"},{"issue":"2","key":"380_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jocs.13978","volume":"34","author":"L Bertoglio","year":"2019","unstructured":"Bertoglio L, Katsarou M, Scandroglio M, Bertoldi L, Chiesa R, Pappalardo F. Surgical transaxillary placement of the Impella 5.0 ventricular assist device. J Card Surg. 2019;34(2):92\u20138.","journal-title":"J Card Surg"},{"issue":"2","key":"380_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40119-019-00152-8","volume":"8","author":"AV Subramaniam","year":"2019","unstructured":"Subramaniam AV, Barsness GW, Vallabhajosyula S, Vallabhajosyula S. Complications of Temporary Percutaneous Mechanical Circulatory support for cardiogenic shock: an Appraisal of Contemporary Literature. Cardiol Ther. 2019;8(2):211\u201328.","journal-title":"Cardiol Ther"},{"issue":"2","key":"380_CR18","first-page":"839","volume":"280","author":"F Roch-Ramel","year":"1997","unstructured":"Roch-Ramel F, Guisan B, Diezi J. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles. J Pharmacol Exp Ther. 1997;280(2):839\u201345.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"380_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ki.1989.206","volume":"36","author":"AM Kahn","year":"1989","unstructured":"Kahn AM. Indirect coupling between sodium and urate transport in the proximal tubule. Kidney Int. 1989;36(3):378\u201384.","journal-title":"Kidney Int"},{"issue":"13","key":"380_CR20","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.3390\/jcm11133749","volume":"11","author":"KJ Chen","year":"2022","unstructured":"Chen KJ, Huang YC, Yao YC, Hsiung W, Chou PH, Wang ST, et al. Risk factors for postsurgical gout flares after Thoracolumbar Spine surgeries. JCM. 2022;11(13):3749.","journal-title":"JCM"},{"issue":"4","key":"380_CR21","doi-asserted-by":"publisher","first-page":"R193","DOI":"10.1186\/ar4026","volume":"14","author":"MA McAdams-DeMarco","year":"2012","unstructured":"McAdams-DeMarco MA, Maynard JW, Coresh J, Baer AN. Anemia and the onset of gout in a population-based cohort of adults: atherosclerosis risk in communities study. Arthritis Res Ther. 2012;14(4):R193.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"380_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5500\/wjt.v11.i11.466","volume":"11","author":"C Kourek","year":"2021","unstructured":"Kourek C, Karatzanos E, Nanas S, Karabinis A, Dimopoulos S. Exercise training in heart transplantation. WJT. 2021;11(11):466\u201379.","journal-title":"WJT"},{"key":"380_CR23","doi-asserted-by":"publisher","first-page":"1759720X2211028","DOI":"10.1177\/1759720X221102853","volume":"14","author":"D DeMizio","year":"2022","unstructured":"DeMizio D, Wu G, Wei Y, Bathon J, Wang R. Gout increases length of stay in patients hospitalized for heart failure exacerbation. Therapeutic Adv Musculoskelet. 2022;14:1759720X2211028.","journal-title":"Therapeutic Adv Musculoskelet"},{"issue":"8","key":"380_CR24","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3899\/jrheum.171320","volume":"45","author":"N Zleik","year":"2018","unstructured":"Zleik N, Elfishawi MM, Kvrgic Z, Michet CJ, Crowson CS, Matteson EL, et al. Hospitalization increases the risk of Acute arthritic flares in gout: a Population-based study over 2 decades. J Rheumatol. 2018;45(8):1188\u201391.","journal-title":"J Rheumatol"},{"key":"380_CR25","doi-asserted-by":"publisher","first-page":"789414","DOI":"10.3389\/fmed.2022.789414","volume":"9","author":"F Ritter","year":"2022","unstructured":"Ritter F, Franzeck F, Geisshardt J, Walker UA, Osthoff M. Gout arthritis during admission for decompensated heart Failure\u2014A descriptive analysis of risk factors, treatment and prognosis. Front Med. 2022;9:789414.","journal-title":"Front Med"},{"issue":"1","key":"380_CR26","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1038\/s41598-021-92673-3","volume":"11","author":"D Benavent","year":"2021","unstructured":"Benavent D, Peiteado D, Martinez-Huedo M\u00c1, Hernandez-Hurtado M, Balsa A, De Miguel E. Healthcare-related impact of gout in hospitalized patients in Spain. Sci Rep. 2021;11(1):13287.","journal-title":"Sci Rep"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-024-00380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-024-00380-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-024-00380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:04:58Z","timestamp":1709165098000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-024-00380-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1186\/s41927-024-00380-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3549951\/v1","asserted-by":"object"}]},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"3 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jessica Blasavage\u2013 Employed by Abiomed in the position of Associate Clinical Consultant. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was deemed exempt by the Mayo Clinic Institutional Review Board, under the IRB number 22-008125. The need for informed consent was waived by the institutional review board, and the study cohort included patients with prior research authorization. Data anonymity and confidentiality were maintained per standard protocol, and the procedures followed the ethical standards of the committee responsible for human experimentation and the Helsinki Declaration of 1975, as well as the ISHLT statement on transplant ethics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the preparation of this work, the authors used ChatGPT 4.0 in order to improve the readability and language of background and discussion. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"9"}}